Interestingly, a study revealed that stromal cells in the tumor microenvironment (TME) could continuously express GAS6 to activate the AXL receptor of adjacent tumor cells, thus promoting cancer drug resistance.123. The gene discussed is GAS6; the disease is neoplasm.